Valeant Pharmaceuticals International, Inc. 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Jan 22, 2014
Insider Transaction Report
Form 4
Schiller Howard Bradley
EVP and CFO
Transactions
- Tax Payment
Common Stock, no par value
2014-01-20−3,000→ 222,704 total - Tax Payment
Common Stock, no par value
2014-01-20−8,284→ 225,704 total
Footnotes (1)
- [F1]This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Matching Restricted Share Units.